FDA daily for Monday, September 7, 2026
In this issue: 123 label changes. 2 items touch categories MedGrid carries, and they come first.
For MedGrid's categories
Items in this issue that name a product category sold on MedGrid. Each links to its full FDA record; the chip opens that category's federal and state rules.
- Exuviance Age Reverse Day Repair with Sunscreen Broad Spectrum SPF 30
AVOBENZONE, OCTINOXATE, AND OCTISALATE · NeoStrata Company Inc. · TOPICAL
Label updates
FDA date:123 drug labels took effect on Mon, Aug 24; 2 of the 25 read for this issue are for products in MedGrid's categories. Below: those, and labels carrying a boxed warning.
- Exuviance Age Reverse Day Repair with Sunscreen Broad Spectrum SPF 30
AVOBENZONE, OCTINOXATE, AND OCTISALATE · NeoStrata Company Inc. · TOPICAL
- DOXEPIN HYDROCHLORIDE
DOXEPIN HYDROCHLORIDE · REMEDYREPACK INC. · ORAL
- Bupropion Hydrochloride
BUPROPION HYDROCHLORIDE · Aphena Pharma Solutions - Tennessee, LLC · ORAL
FDA did not answer for Drug recalls, Food and supplement recalls, Clearances, Approvals, Device recalls, Drug shortages while this issue was written; those sections will fill in on a later visit.
How the FDA daily is written
Every issue is written from FDA's public data (openFDA) and nothing else: the counts, names, firms and reasons are FDA's own. openFDA posts each kind of record on its own delay, so each section covers one FDA date and says which. Shortages cover yesterday; approvals, drug and device recalls, and food and supplement recalls cover a week ago; device clearances and label changes cover two weeks ago. Every FDA date appears in exactly one issue. Complete response letters appear the day after FDA publishes a batch.
Subscribe with any feed reader, or point an email tool at the RSS feed to send each issue as a newsletter. Search any drug, device or company across every FDA dataset in the FDA data explorer.
